The inspiration behind this project stemmed from the challenges faced during the distribution of COVID-19 vaccines, particularly the complex and costly process of shipping them under specific conditions. By enabling localized production of medicines, especially those tailored for individual patients, the NANOSPRESSO-NL device could significantly reduce these logistical hurdles.
NANOSPRESSO is funded by the Dutch Research Agenda (NWA) ORC 2020/21 program. For more information about our partners, funding, and legal notices, please visit our contact page and follow us on social media.